19 followers
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis. https://t.co/YzezGLwsAB
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis. https://t.co/YzezGLwsAB
Alemtuzumab versus interferon beta 1a for relapsing-remitting #multiplesclerosis https://t.co/0CtUSmFNg0 https://t.co/dW3hSBdtvv
Cochrane review on alemtuzumab versus interferon beta 1a for relapsing-remitting #MS available at: https://t.co/ynIwx2AP4U
Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis. - PubMed - NCBI https://t.co/YIMYfSFilF